These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 33613415)

  • 21. The functional neuroimaging correlates of psychogenic versus organic dystonia.
    Schrag AE; Mehta AR; Bhatia KP; Brown RJ; Frackowiak RS; Trimble MR; Ward NS; Rowe JB
    Brain; 2013 Mar; 136(Pt 3):770-81. PubMed ID: 23436503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dystonia: diagnosis and management.
    Albanese A; Di Giovanni M; Lalli S
    Eur J Neurol; 2019 Jan; 26(1):5-17. PubMed ID: 30035844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional dystonia: A case-control study and risk prediction algorithm.
    Stephen CD; Perez DL; Chibnik LB; Sharma N
    Ann Clin Transl Neurol; 2021 Apr; 8(4):732-748. PubMed ID: 33724724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Botulinum toxin for treatment of the focal dystonia].
    Nakamura Y
    Rinsho Shinkeigaku; 2017 Jul; 57(7):367-372. PubMed ID: 28652522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural, functional and molecular imaging of the brain in primary focal dystonia--a review.
    Zoons E; Booij J; Nederveen AJ; Dijk JM; Tijssen MA
    Neuroimage; 2011 Jun; 56(3):1011-20. PubMed ID: 21349339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-Motor Symptoms in Cervical Dystonia: A Review.
    Ray S; Pal PK; Yadav R
    Ann Indian Acad Neurol; 2020; 23(4):449-457. PubMed ID: 33223660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional dystonia and the borderland between neurology and psychiatry: New concepts.
    Newby R; Alty J; Kempster P
    Mov Disord; 2016 Dec; 31(12):1777-1784. PubMed ID: 27753149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.
    Yoshida K
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoids and dystonia: an issue yet to be defined.
    Mascia MM; Carmagnini D; Defazio G
    Neurol Sci; 2020 Apr; 41(4):783-787. PubMed ID: 31848779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of dystonia.
    Jankovic J
    Lancet Neurol; 2006 Oct; 5(10):864-72. PubMed ID: 16987733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Network-level connectivity is a critical feature distinguishing dystonic tremor and essential tremor.
    DeSimone JC; Archer DB; Vaillancourt DE; Wagle Shukla A
    Brain; 2019 Jun; 142(6):1644-1659. PubMed ID: 30957839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical dystonia pathophysiology and treatment options.
    Velickovic M; Benabou R; Brin MF
    Drugs; 2001; 61(13):1921-43. PubMed ID: 11708764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin injection for the treatment of oromandibular dystonia.
    Blitzer A; Brin MF; Greene PE; Fahn S
    Ann Otol Rhinol Laryngol; 1989 Feb; 98(2):93-7. PubMed ID: 2916831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebellum involvement in dystonia: insights from a spiking neural network model during associative learning.
    Geminiani A; Mockevicius A; D'Angelo E; Casellato C
    Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():5132-5135. PubMed ID: 36086302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olfaction as a Marker for Dystonia: Background, Current State and Directions.
    Herr T; Gamain J; Fleischmann R; Lehnert B; Vollmer M; Willert C; Veit B; Stenner A; Mueller JU; Caspers B; Kronenbuerger M
    Brain Sci; 2020 Oct; 10(10):. PubMed ID: 33066144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Task-free functional MRI in cervical dystonia reveals multi-network changes that partially normalize with botulinum toxin.
    Delnooz CC; Pasman JW; Beckmann CF; van de Warrenburg BP
    PLoS One; 2013; 8(5):e62877. PubMed ID: 23650536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical characteristics and treatment of dystonia].
    Mezaki T
    Rinsho Shinkeigaku; 2011 Jul; 51(7):465-70. PubMed ID: 21823504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional MRI connectivity of the primary motor cortex in functional dystonia patients.
    Piramide N; Sarasso E; Tomic A; Canu E; Petrovic IN; Svetel M; Basaia S; Dragasevic Miskovic N; Kostic VS; Filippi M; Agosta F
    J Neurol; 2022 Jun; 269(6):2961-2971. PubMed ID: 34773159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Opinions and Areas of Consensus on the Role of the Cerebellum in Dystonia.
    Shakkottai VG; Batla A; Bhatia K; Dauer WT; Dresel C; Niethammer M; Eidelberg D; Raike RS; Smith Y; Jinnah HA; Hess EJ; Meunier S; Hallett M; Fremont R; Khodakhah K; LeDoux MS; Popa T; Gallea C; Lehericy S; Bostan AC; Strick PL
    Cerebellum; 2017 Apr; 16(2):577-594. PubMed ID: 27734238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.